Polatuzumab Vedotin | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Polatuzumab Vedotin
Health Canada Patents

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

Contact Supplier

Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

Contact Supplier

Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Contact Supplier

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

Polatuzumab Vedotin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

48 Drugs in Development

48 Drugs in Development

FINISHED DOSAGE FORMULATIONS

8 FDF Dossiers, 2 FDA Orange Book, 2 Europe, 2 Canada, 2 South Africa

8 FDF Dossiers
2 FDA Orange Book
2 Europe
2 Canada
2 South Africa

DIGITAL CONTENT

33 News #PharmaBuzz

33 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 5 Annual Reports

1 US Medicaid Prescriptions
2 Regulatory FDF Prices
5 Annual Reports

PATENTS & EXCLUSIVITIES

8 Health Canada Patents

8 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

8 All

01 8Gowling WLG (Canada) LLP

filter Patent Reset all filters

8 All

01 22494105

02 22693255

03 22841741

04 22979671

filter Product Reset all filters

8 All

01 8POLATUZUMAB VEDOTIN

filter Dosage Reset all filters

8 All

01 8POWDER FOR SOLUTION

filter Exp Date Reset all filters

8 All

01 22023-07-31

02 22024-11-05

03 22028-07-15

04 22035-09-23

Product Main Page

01

Gowling WLG (Canada) LLP

POLATUZUMAB VEDOTIN

ESCRS

Not Confirmed

Gowling WLG (Canada) LLP

Country

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-11-05

Date Granted : 2020-01-07

POLATUZUMAB VEDOTIN

Brand Name : POLIVY

Patent Number : 2841741

Filing Date : 2004-11-05

Strength per Unit : 140mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2024-11-05

Date Granted : 2020-01-07

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gowling WLG (Canada) LLP

POLATUZUMAB VEDOTIN

ESCRS

Not Confirmed

Gowling WLG (Canada) LLP

Country

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-09-23

Date Granted : 2020-03-10

POLATUZUMAB VEDOTIN

Brand Name : POLIVY

Patent Number : 2979671

Filing Date : 2015-09-23

Strength per Unit : 140mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2035-09-23

Date Granted : 2020-03-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Gowling WLG (Canada) LLP

POLATUZUMAB VEDOTIN

ESCRS

Not Confirmed

Gowling WLG (Canada) LLP

Country

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-07-31

Date Granted : 2013-04-02

POLATUZUMAB VEDOTIN

Brand Name : POLIVY

Patent Number : 2494105

Filing Date : 2003-07-31

Strength per Unit : 140mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2023-07-31

Date Granted : 2013-04-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gowling WLG (Canada) LLP

POLATUZUMAB VEDOTIN

ESCRS

Not Confirmed

Gowling WLG (Canada) LLP

Country

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-07-15

Date Granted : 2020-02-25

POLATUZUMAB VEDOTIN

Brand Name : POLIVY

Patent Number : 2693255

Filing Date : 2008-07-15

Strength per Unit : 140mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2028-07-15

Date Granted : 2020-02-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Gowling WLG (Canada) LLP

POLATUZUMAB VEDOTIN

ESCRS

Not Confirmed

Gowling WLG (Canada) LLP

Country

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-07-31

Date Granted : 2013-04-02

POLATUZUMAB VEDOTIN

Brand Name : POLIVY

Patent Number : 2494105

Filing Date : 2003-07-31

Strength per Unit : 30mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2023-07-31

Date Granted : 2013-04-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Gowling WLG (Canada) LLP

POLATUZUMAB VEDOTIN

ESCRS

Not Confirmed

Gowling WLG (Canada) LLP

Country

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-07-15

Date Granted : 2020-02-25

POLATUZUMAB VEDOTIN

Brand Name : POLIVY

Patent Number : 2693255

Filing Date : 2008-07-15

Strength per Unit : 30mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2028-07-15

Date Granted : 2020-02-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Gowling WLG (Canada) LLP

POLATUZUMAB VEDOTIN

ESCRS

Not Confirmed

Gowling WLG (Canada) LLP

Country

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-11-05

Date Granted : 2020-01-07

POLATUZUMAB VEDOTIN

Brand Name : POLIVY

Patent Number : 2841741

Filing Date : 2004-11-05

Strength per Unit : 30mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2024-11-05

Date Granted : 2020-01-07

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Gowling WLG (Canada) LLP

POLATUZUMAB VEDOTIN

ESCRS

Not Confirmed

Gowling WLG (Canada) LLP

Country

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-09-23

Date Granted : 2020-03-10

POLATUZUMAB VEDOTIN

Brand Name : POLIVY

Patent Number : 2979671

Filing Date : 2015-09-23

Strength per Unit : 30mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2035-09-23

Date Granted : 2020-03-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!